Evidence map›Paper›PMID 26340922›Full record

ArticleCardiovascular ultrasound2015

Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients.

Miodrag Dikic, Milorad Tesic, Zeljko Markovic, Vojislav Giga, Ana Djordjevic-Dikic, Jelena Stepanovic, Branko Beleslin, Ivana Jovanovic, Ana Mladenovic, Jelena Seferovic and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular ultrasound, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Miodrag DikicClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. miodrag.dikic@gmail.com.
Milorad TesicClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. misa.tesic@gmail.com.
Zeljko MarkovicMedical School, University of Belgrade, Belgrade, Serbia. dr.markovic@gmail.com.
Vojislav GigaClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. voja2011@yahoo.com.
Ana Djordjevic-DikicClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. skali.ana7@gmail.com.
Jelena StepanovicClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. jelena.stepanovic@kcs.ac.rs.
Branko BeleslinClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. branko.beleslin@gmail.com.
Ivana JovanovicClinic for Cardiology, Clinical Center of Serbia, Visegradska 26, 11000, Belgrade, Serbia. ivana170679@gmail.com.
Ana MladenovicClinic for Radiology, Clinical Center of Serbia, Belgrade, Serbia. anicak@yahoo.com.
Jelena SeferovicMedical School, University of Belgrade, Belgrade, Serbia. jpseferovic@gmail.com.
Miodrag OstojicMedical School, University of Belgrade, Belgrade, Serbia. mostojic2003@yahoo.com.
Aleksandra ArandjelovicMedical School, University of Belgrade, Belgrade, Serbia. drarandjelovic@yahoo.com.
Centar za Promociju Nauke · RSUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe risk stratification of patients with diabetes mellitus (DM) is a major objective for the clinicians, and it can be achieved by coronary flow velocity reserve (CFVR) or with coronary artery calcium score (CS). CS evaluates underlying coronary atherosclerotic plaque burden and CFVR estimates both presence of coronary artery stenosis and microvascular function. Consequently, CFVR may provide unique risk information beyond the extent of coronary atherosclerosis.

aimOur aim is to assess joint prognostic value of CFVR and CS in asymptomatic DM patients. MATERIALS AND

methodsWe prospectively included 200 asymptomatic patients (45,5 % male, mean age 57,35 ± 11,25), out of which, there were 101 asymptomatic patients with DM and 99 asymptomatic patients without DM, but with one or more conventionally risk factors for coronary artery disease. We analyzed clinical, biochemical, metabolic, inflammatory parameters, CS by Agatston method, transthoracic Doppler echocardiography CFVR of left anterior descending artery and echocardiographic parameters.

resultsTotal CS and CS LAD were significantly higher, while mean CFVR was lower in diabetics compared to the nondiabetics. During 1 year follow-up, 24 patients experienced cardio-vascular events (one cardiovascular death, two strokes, three myocardial infarctions, nine new onsets of unstable angina and nine myocardial revascularizations): 19 patients with DM and five non DM patients, (p = 0,003). Overall event free survival was significantly higher in non DM group, compared to the DM group (94,9 % vs. 81,2 %, p = 0,002 respectively), while the patients with CS ≥200 and CFVR <2 had the worst outcome during 1 year follow up in the whole study population as well as in the DM group. At multivariable analysis CFVR on LAD (HR 12.918, 95 % CI 3.865-43.177, p < 0.001) and total CS (HR 13.393, 95 % CI 1.675-107.119, p = 0.014) were independent prognostic predictors of adverse events in DM group of patients.

conclusionBoth CS and CFVR provide independent and complementary prognostic information in asymptomatic DM patients. When two parameters are analyzed together, the risk stratification ability improves, even when DM patients are analyzed together with non DM patients. As a result, DM patients with CS ≥200 and CFVR <2 had the worst outcome. Consequently, the use of two tests identified subset of patients who can derive the most benefit from the intensive prevention measures.

Indexed as

Fractional Flow Reserve, MyocardialAsymptomatic DiseasesCalcinosisCausalityComorbidityCoronary Artery DiseaseDiabetes ComplicationsEchocardiographyFemaleHumansMaleMiddle AgedPrognosisReproducibility of ResultsRisk AssessmentSensitivity and Specificity

Identifiers

PMID26340922
PMCPMC4560883
OpenAlexW2130564434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.